PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
1429.41%
Net income growth above 1.5x MRVL's 2.04%. David Dodd would see a clear bottom-line advantage if it is backed by stable operations.
-2.92%
Both reduce yoy D&A, with MRVL at -1.32%. Martin Whitman would suspect a lull in expansions or intangible additions for both.
100.00%
Well above MRVL's 100.00% if it’s a large positive yoy. Michael Burry would see a bigger future tax burden vs. competitor’s approach.
-6.00%
Both cut yoy SBC, with MRVL at -100.00%. Martin Whitman would view it as an industry shift to reduce stock-based pay or a sign of reduced expansions.
80.61%
Well above MRVL's 113.17% if positive yoy. Michael Burry would see a risk of bigger working capital demands vs. competitor, harming free cash flow.
46.79%
AR growth is negative or stable vs. MRVL's 100.00%, indicating tighter credit discipline. David Dodd would confirm it doesn't hamper sales volume.
-86.74%
Both reduce yoy inventory, with MRVL at -15.22%. Martin Whitman would find a widespread caution or cyclical demand drop in the niche.
100.00%
AP growth well above MRVL's 100.00%. Michael Burry would be concerned about potential late payments or short-term liquidity strain relative to competitor.
250.00%
Some yoy usage while MRVL is negative at -1483.14%. John Neff would see competitor possibly generating more free cash from minor accounts than we do.
-23.08%
Negative yoy while MRVL is 772.54%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
121.91%
Operating cash flow growth above 1.5x MRVL's 40.47%. David Dodd would confirm superior cost control or stronger revenue-to-cash conversion.
-11.63%
Negative yoy CapEx while MRVL is 43.45%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
50.96%
Acquisition growth of 50.96% while MRVL is zero at 0.00%. Bruce Berkowitz sees a mild outflow that must deliver synergy to justify the difference.
-55.86%
Negative yoy purchasing while MRVL stands at 99.55%. Joel Greenblatt sees a near-term liquidity advantage unless competitor’s new investments produce outsized returns.
-19.81%
Both yoy lines are negative, with MRVL at -100.00%. Martin Whitman suspects an environment prompting fewer sales or fewer maturities within the niche.
No Data
No Data available this quarter, please select a different quarter.
-60.88%
Both yoy lines negative, with MRVL at -2.68%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
100.00%
Debt repayment similar to MRVL's 100.00%. Walter Schloss sees parallel liability management or similar free cash flow availability.
5.56%
Lower share issuance yoy vs. MRVL's 196.72%, implying less dilution. David Dodd would confirm the firm still has enough capital for expansions.
-147.52%
We cut yoy buybacks while MRVL is 0.00%. Joel Greenblatt would question if competitor is gaining a per-share edge unless expansions justify holding cash here.